Similar articles

• Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia.

  Balcerzak SP, Grever MR, Sing DE, Bishop JN, Segal ML. Balcerzak SP, et al. J Lab Clin Med. 1982 Sep;100(3):345-55. J Lab Clin Med. 1982. PMID: 7108349
• Measurement of the carbamylation kinetics and antisickling mechanism in hemoglobin S blood.

  Uvelli DA, Lee MY, Manning JM, Hlastala MP, Babb AL. Uvelli DA, et al. J Lab Clin Med. 1980 May;95(5):748-58. J Lab Clin Med. 1980. PMID: 7365317
• Cyanate as an inhibitor of red-cell sickling.

  Cerami A. Cerami A. N Engl J Med. 1972 Oct 19;287(16):807-12. doi: 10.1056/NEJM197210192871606. N Engl J Med. 1972. PMID: 4560520 Review. No abstract available.
• Advances in the understanding of sickle cell anemia.

  Charache S. Charache S. Hosp Pract (Off Ed). 1986 Feb 15;21(2):173-8, 182-90. doi: 10.1080/21548331.1986.11706577. Hosp Pract (Off Ed). 1986. PMID: 2419352 No abstract available.
• New Approaches to the therapy of sickle cell disease.

  Luskey KL, Schechter AN, Hercules JI. Luskey KL, et al. Tex Rep Biol Med. 1980-1981;40:305-12. Tex Rep Biol Med. 1980. PMID: 6172868 Review. No abstract available.